X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
enteroinsular axis (187) 187
animals (93) 93
humans (82) 82
glucagon-like peptide-1 (81) 81
male (78) 78
endocrinology & metabolism (70) 70
gastric-inhibitory polypeptide (65) 65
female (60) 60
insulin secretion (54) 54
glucose (53) 53
insulin - metabolism (53) 53
index medicus (52) 52
insulin - blood (51) 51
mice (47) 47
insulin (46) 46
gip (45) 45
gastric inhibitory polypeptide - metabolism (44) 44
glucagon (44) 44
blood glucose - metabolism (41) 41
secretion (41) 41
glucagon-like peptide 1 (39) 39
incretin (37) 37
adult (36) 36
rats (31) 31
obesity (30) 30
physiology (29) 29
glucose tolerance test (28) 28
medicine & public health (28) 28
diabetes (25) 25
gastric inhibitory polypeptide (25) 25
glp-1 (24) 24
glucagon - metabolism (23) 23
middle aged (23) 23
dependent insulinotropic polypeptide (22) 22
incretin hormones (22) 22
pancreas (22) 22
time factors (22) 22
gastric inhibitory polypeptide - pharmacology (21) 21
glucagon-like peptides (21) 21
gastric inhibitory polypeptide - blood (20) 20
insulin resistance (20) 20
blood glucose - analysis (19) 19
dextrose (19) 19
diabetes-mellitus (19) 19
internal medicine (19) 19
medicine, research & experimental (19) 19
mice, knockout (19) 19
peptide fragments - metabolism (19) 19
rat (19) 19
receptors, gastrointestinal hormone - genetics (19) 19
receptors, gastrointestinal hormone - metabolism (19) 19
type 2 diabetes (19) 19
gastric inhibitory polypeptide - physiology (18) 18
glucose-dependent insulinotropic polypeptide (18) 18
human physiology (18) 18
metabolic diseases (18) 18
biochemistry & molecular biology (17) 17
endocrine system (17) 17
glucagon - blood (17) 17
glucose - metabolism (17) 17
diabetes mellitus, type 2 - blood (16) 16
diabetes mellitus, type 2 - drug therapy (16) 16
glucose metabolism (16) 16
mice, inbred c57bl (16) 16
peptide fragments - pharmacology (16) 16
physiological aspects (16) 16
insulin-secreting cells - metabolism (15) 15
pancreas - metabolism (15) 15
glucose-intolerance (14) 14
hormones, hormone substitutes, and hormone antagonists (14) 14
in-vitro (14) 14
islets of langerhans - metabolism (14) 14
nutrition & dietetics (14) 14
release (14) 14
7-36 amide (13) 13
bariatric surgery (13) 13
c-peptide - blood (13) 13
diabetes mellitus, type 2 - metabolism (13) 13
gastric inhibitory polypeptide - genetics (13) 13
glycemic control (13) 13
hormones (13) 13
incretins (13) 13
glucagon-like peptide 1 - metabolism (12) 12
glucose - pharmacology (12) 12
hormone (12) 12
polypeptide (12) 12
research (12) 12
surgery (12) 12
abridged index medicus (11) 11
aged (11) 11
diabetes mellitus, type 2 - physiopathology (11) 11
glucagon-like peptide-1 receptor (11) 11
incretins - metabolism (11) 11
insulin-secretion (11) 11
metabolism (11) 11
oral glucose (11) 11
receptor (11) 11
type-2 diabetes-mellitus (11) 11
body weight (10) 10
expression (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetologia, ISSN 0012-186X, 5/2015, Volume 58, Issue 5, pp. 1091 - 1099
Glucose-lowering therapy with dipeptidyl peptidase-4 (DPP-4) inhibitors is associated with a low risk of hypoglycaemia. We hypothesise that DPP-4 inhibition... 
Glucose-dependent insulinotropic polypeptide | Medicine & Public Health | Human Physiology | Entero–islet axis | Glucagon | Hypoglycaemia | DPP-4 inhibitor | Metabolic Diseases | Internal Medicine | Glucagon secretion | Hypoglycaemic clamp | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | REDUCES GLUCAGON | BLOOD-GLUCOSE | ENTEROINSULAR AXIS | Entero-islet axis | IMPROVES GLYCEMIC CONTROL | VILDAGLIPTIN | ENDOCRINOLOGY & METABOLISM | HORMONE RESPONSES | DEPENDENT INSULINOTROPIC POLYPEPTIDE | SECRETION | GLUCOSE-TOLERANCE | Receptors, Glucagon - genetics | Adamantane - pharmacology | Gastric Inhibitory Polypeptide - metabolism | Nitriles - pharmacology | Receptors, Glucagon - metabolism | Hypoglycemia - metabolism | Receptors, Gastrointestinal Hormone - metabolism | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Mice, Knockout | Pyrrolidines - pharmacology | Hypoglycemia - prevention & control | Animals | Signal Transduction - drug effects | Receptors, Gastrointestinal Hormone - genetics | Glucagon - metabolism | Signal Transduction - physiology | Mice | Blood Glucose - metabolism | Gastric Inhibitory Polypeptide - pharmacology | Adamantane - analogs & derivatives | Dextrose | Glucose | Clinical Medicine | Endokrinologi och diabetes | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Endocrinology and Diabetes
Journal Article
Obesity Surgery, ISSN 0960-8923, 06/2004, Volume 14, Issue 6, pp. 840 - 848
The Roux-en-Y gastric bypass (RYGBP) and the biliopancreatic diversion (BPD) induce long-term control of type 2 diabetes in morbidly obese individuals. The... 
GASTRIC BYPASS | GLP-1 | Medicine & Public Health | Surgery | BILIOPANCREATIC DIVERSION | ENTEROINSULAR AXIS | BARIATRIC SURGERY | DIABETES TYPE 2 | ILEOJEJUNAL TRANSPOSITION | GIP | MORBID OBESITY | Enteroinsular axis | Biliopancreatic diversion | Ileojejunal transposition | Bariatric surgery | Gastric bypass | Morbid obesity | Diabetes type 2 | morbid obesity | SURGERY | enteroinsular axis | bariatric surgery | VERTICAL BANDED GASTROPLASTY | FOOD-INTAKE | INSULIN-SECRETION | biliopancreatic diversion | ileojejunal transposition | ILEAL TRANSPOSITION | GLUCAGON-LIKE PEPTIDE-1 | THERAPEUTIC AGENTS | MORBID-OBESITY | diabetes type 2 | GASTRIC-INHIBITORY POLYPEPTIDE | gastric bypass | Obesity | Gastric Bypass | Glucagon-Like Peptide 1 | Peptide Fragments - metabolism | Gastric Inhibitory Polypeptide - metabolism | Pancreas - physiopathology | Obesity, Morbid - surgery | Humans | Glucagon - physiology | Insulin - blood | Postprandial Period - physiology | Protein Precursors - metabolism | Down-Regulation - physiology | Peptide Fragments - physiology | Gastric Inhibitory Polypeptide - physiology | Diabetes Mellitus, Type 2 - physiopathology | Obesity, Morbid - physiopathology | Diabetes Mellitus - physiopathology | Insulin Resistance - physiology | Protein Precursors - physiology | Glucagon - metabolism | Ileum - physiopathology | Blood Glucose - metabolism | Diabetes Mellitus - surgery | Type 2 diabetes | Diabetics | Gastrointestinal hormones | Knowledge-based systems | Weight control | Diabetes | Gastrointestinal surgery
Journal Article
Obesity Surgery, ISSN 0960-8923, 05/2005, Volume 15, Issue 5, pp. 692 - 699
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra151 - 209ra151
We report the discovery and translational therapeutic efficacy of a peptide with potent, balanced co-agonism at both of the receptors for the incretin hormones... 
MEDICINE, RESEARCH & EXPERIMENTAL | BODY-WEIGHT | GLYCEMIC CONTROL | HIGH-FAT DIET | GLUCOSE-INTOLERANCE | ENTEROINSULAR AXIS | PANCREATIC BETA-CELLS | DEPENDENT INSULINOTROPIC POLYPEPTIDE | GASTRIC-INHIBITORY POLYPEPTIDE | LIPOPROTEIN-LIPASE | PEPTIDE YY3-36 | CELL BIOLOGY | Acylation - drug effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Male | Rodentia - metabolism | Weight Loss - drug effects | Hyperglycemia - drug therapy | Young Adult | Incretins - pharmacology | Adult | Female | Gastric Inhibitory Polypeptide - pharmacology | Receptors, Glucagon - agonists | Glucose Tolerance Test | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Rats | Receptors, Glucagon - metabolism | Treatment Outcome | Haplorhini - metabolism | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Adolescent | Aged | Mice | Venoms - pharmacology | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Receptors, Gastrointestinal Hormone | Incretins - administration & dosage | Liraglutide | Medicin och hälsovetenskap | Medicinsk bioteknologi (inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinsk bioteknologi
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 06/2019, Volume 513, Issue 4, pp. 974 - 982
Caloric restriction (CR) promotes longevity and exerts anti-aging effects by increasing Sirtuin production and activation. Gastric inhibitory polypeptide... 
Mouse | Gene expression | Adipose tissue | OXIDATIVE STRESS | BIOCHEMISTRY & MOLECULAR BIOLOGY | METABOLIC ADAPTATION | ENTEROINSULAR AXIS | MIXED MEAL | RECEPTOR | LONGEVITY | BIOPHYSICS | GLUCAGON-LIKE PEPTIDE-1 | INSULIN-RESISTANCE | ADIPOSE-TISSUE | POLYPEPTIDE
Journal Article
Journal Article
Nutricion Hospitalaria, ISSN 0212-1611, 2013, Volume 28, Issue 2, pp. 95 - 103
Journal Article
Cell Metabolism, ISSN 1550-4131, 01/2017, Volume 25, Issue 1, pp. 152 - 165
Journal Article
Journal of Animal Science, ISSN 0021-8812, 07/2015, Volume 93, Issue 7, pp. 3377 - 3383
The enteroinsular axis is a complex system that includes the release of incretin hormones from the gut to promote the absorption and utilization of glucose... 
Incretin | Glucagon-like peptide-1 | Equine | Glucose | Laminitis | Insulin | STANDARD-BRED HORSES | glucose | AGRICULTURE, DAIRY & ANIMAL SCIENCE | RISK-FACTORS | insulin | incretin | glucagon-like peptide-1 | ENTEROINSULAR AXIS | HYPERINSULINEMIA | INFUSION | CONDITION SCORE | HORMONE | laminitis